Lasky & Rifkind file complaint over Northfield Laboratories Inc
A complaint has been filed in respect of securities in Northfield Laboratories Inc by Lasky & Rifkind.
The complaint alleges that Defendants violated Sections 10(b) and20(a) of the Securities Exchange Act of 1934 and Rule 10b-5promulgated thereunder. Specifically, the complaint alleges thatDefendants issued a series of materially false and misleadingstatements regarding the safety of PolyHeme, a blood substitute. Morespecifically, the Company failed to disclose negative data from an ANHstudy concerning ten patients who had heart attacks within seven daysof taking PolyHeme, and that two of those patients had subsequentlydied.
Full details here
The complaint alleges that Defendants violated Sections 10(b) and20(a) of the Securities Exchange Act of 1934 and Rule 10b-5promulgated thereunder. Specifically, the complaint alleges thatDefendants issued a series of materially false and misleadingstatements regarding the safety of PolyHeme, a blood substitute. Morespecifically, the Company failed to disclose negative data from an ANHstudy concerning ten patients who had heart attacks within seven daysof taking PolyHeme, and that two of those patients had subsequentlydied.
Full details here
posted by JohnBowie at 12:21 PM
0 Comments:
Post a Comment
<< Home